| Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
|---|
| 09/20/2000 | CN1267290A Tricyclic sulfonamide inhibitors of farnesyl-protein transferase |
| 09/20/2000 | CN1267288A Tricyclic keto amide derivs. useful as farnesyl protein transferase inhibitors |
| 09/20/2000 | CN1056611C Pyrazolo and pyrrolopyridines, their use and intermidiates for preparing same |
| 09/19/2000 | US6121450 Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors |
| 09/19/2000 | US6121279 Phosphodiesterase inhibitor for treating respiratory system disorders |
| 09/19/2000 | US6121278 Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity |
| 09/19/2000 | US6121277 Antitumor agents |
| 09/19/2000 | US6120703 Derivatives of 6-fluorophenanthridine for liquid crystal mixtures |
| 09/14/2000 | WO2000053608A1 Pyridopyranoazepine derivatives, preparation and therapeutic use |
| 09/14/2000 | WO2000004012A8 COMPOUNDS SPECIFIC FOR THE HUMAN α1d ADRENERGIC RECEPTOR AND USES THEREOF |
| 09/14/2000 | WO1999063999A8 H1-histamine receptor antagonists |
| 09/13/2000 | EP1034221A1 Dibenzorhodamine dyes useful as fluorescent labelling agents |
| 09/13/2000 | CN1266434A 1,2,4-triazolo [4,3-B] pyrido [3,2-D] pyridazine derivatives and pharmaceutical compositions containing them |
| 09/13/2000 | CN1056373C Process for preparation of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles |
| 09/12/2000 | US6117883 Useful for modulating a muscarinic receptor. |
| 09/12/2000 | US6117881 N-cinnamoyl derivatives of (β) carbolines |
| 09/12/2000 | US6117880 Treatment of diabetes, retinopathy, restinosis, acromegaly, and depression |
| 09/12/2000 | CA2047773C Derivatives of benzofuran, benzothiophene, indole and indolizine, process for their preparation as well as the compositions containing them |
| 09/08/2000 | WO2000052099A1 Bichromophoric perylene-3,4-dicarboximides |
| 09/08/2000 | WO2000051986A1 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 09/08/2000 | CA2330541A1 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 09/06/2000 | EP1032556A1 Pharmaceutically active compounds and methods of use |
| 09/06/2000 | EP1032555A1 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 09/05/2000 | US6114175 Amyloid-binding compounds which are non-azo derivatives of chrysamine g to determine degree of brain deposits quantitatively characterized by amyloidosis; down's syndrome; prevent cell degeneration; radioactive imaging |
| 08/31/2000 | WO2000050397A1 Substituted piperidinedione derivatives and herbicide |
| 08/29/2000 | US6111116 Dibenzorhodamine dyes |
| 08/29/2000 | US6111110 Synthesis of benzo[f]quinolinones |
| 08/29/2000 | US6110938 1-(arylthioalkyl, arylaminoalkyl or arylmethylenealkyl)-4-(heteroaryl)piperidines and related compounds useful as antipsychotics and analgesics |
| 08/29/2000 | US6110930 Nitric oxide synthase inhibitor |
| 08/29/2000 | US6110929 Immunomodulators which induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor and inhibit t-helper-type 2 immune response; for treatment of viral and neoplastic diseases |
| 08/29/2000 | US6110910 Antiinflammatory agents, antiarthritic agents, antirheumatic agents, anticarcinogenic agents |
| 08/24/2000 | WO2000048999A1 Morphan derivatives or salts thereof and medicinal compositions containing the same |
| 08/23/2000 | EP1029016A1 Novel chemiluminescent labeling compounds |
| 08/23/2000 | CN1264300A Arylsubstituted piperazines useful in the threatement of bening prostatic hyperlasia |
| 08/22/2000 | US6107300 Arylamino fused pyrimidines |
| 08/17/2000 | WO2000047571A1 Piperidine and piperazine derivatives as inhibitors of the abeta fibril formation |
| 08/17/2000 | WO2000047562A1 Spirocyclic ketones and their use as tachykinin antagonists |
| 08/17/2000 | CA2362389A1 Piperidine and piperazine derivatives as inhibitors of the abeta fibril formation |
| 08/17/2000 | CA2362272A1 Spirocyclic ketones and their use as tachykinin antagonists |
| 08/16/2000 | CN1055474C Noval crystal type anhydrous 7-([1 alpha, 5 alpha, 6 alpha]=6-amino-3-azabicyclo [3,1,0] hexyl-3-group)-6-fluorine-1-(2,4-difluorophenyl |
| 08/15/2000 | US6103721 Heteroaryl-substituted pyridazino quinoline compounds |
| 08/10/2000 | WO2000046205A1 Aryloxy-poly(oxyalkylene) naphthalimide derivative colorants |
| 08/10/2000 | WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors |
| 08/09/2000 | EP1026157A2 Method for the synthesis of huperzine A and analogs thereof and compounds useful therein |
| 08/09/2000 | CN1262622A Combination therapy for modulating human sexual response |
| 08/08/2000 | US6100267 Enzyme inhibitor for treatment of neurodegenerative disorders, strokes, traumatic brain injury, cataracts |
| 08/03/2000 | WO2000032175A3 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY |
| 08/02/2000 | CN1261906A Alkyl, alkenyl and alkynyl chrysamine G derivatives for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 08/02/2000 | CN1261610A Method for preparing deep colour perylene dye |
| 08/01/2000 | CA2015034C Piperazine derivatives |
| 07/27/2000 | WO2000023433A8 Substituted benzopyran analogs for the treatment of inflammation |
| 07/27/2000 | WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors |
| 07/26/2000 | EP1021415A1 Tricyclic aminoalkylcarboxamides; novel dopamine d 3? receptor subtype specific ligands |
| 07/26/2000 | EP1021397A1 Benzanthrone compounds and antiviral uses thereof |
| 07/26/2000 | CN1054845C Quinoline compounds, their preparing methods and medicinal compositions |
| 07/25/2000 | US6093834 Colorants, in particular as pigments and dyes, vat dyes or mordant dyes, paints, paint systems, in particular automotive lacquers, coating compositions, paper colors, printing colors, inks, in security marking purposes |
| 07/25/2000 | US6093821 Process for preparing steroid receptor modulator compounds |
| 07/25/2000 | US6093732 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| 07/25/2000 | US6093724 Muscarinic agonists and antagonists |
| 07/20/2000 | WO2000042040A1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 07/20/2000 | WO2000042020A1 Phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042019A1 6-arylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042018A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042017A1 Phenanthridine-n-oxides with pde-iv inhibiting activity |
| 07/20/2000 | CA2360386A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | CA2359416A1 6-arylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | CA2359404A1 Phenanthridine-n-oxides with pde-iv inhibiting activity |
| 07/19/2000 | EP1020446A1 Naphthalimidobenzamide derivatives |
| 07/19/2000 | EP1019720A1 Combinatorial process for preparing tetrahydroquinoline libraries |
| 07/19/2000 | EP1019398A1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives useful for inhibition of farnesyl protein transferase |
| 07/19/2000 | EP1019388A1 Preparation of perylene-3,4-dicarboxylic anhydrides |
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/18/2000 | US6090808 Dimeric piperidine, tetrahydropyridine and piperazine derivatives |
| 07/12/2000 | EP1017677A1 4-phenyltetrahydrochinoline utilized as an inhibitor of the cholesterol ester transfer protein |
| 07/11/2000 | CA2188385C Dosage forms and method for ameliorating male erectile dysfunction |
| 07/06/2000 | WO2000039108A1 Thrombin or factor xa inhibitors |
| 07/06/2000 | WO2000039102A1 THROMBIN OR FACTOR Xa INHIBITORS |
| 07/06/2000 | WO2000038683A1 THROMBIN OR FACTOR Xa INHIBITORS |
| 07/06/2000 | WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 07/06/2000 | CA2349557A1 Thrombin or factor xa inhibitors |
| 07/06/2000 | CA2348740A1 Thrombin or factor xa inhibitors |
| 07/06/2000 | CA2320730A1 Thrombin or factor xa inhibitors |
| 07/05/2000 | EP1015461A1 Novel compounds for generating chemiluminescence with a peroxidase |
| 07/05/2000 | EP1015459A1 Tetrazole-containing rapamycin analogs with shortened half-lives |
| 07/05/2000 | EP1015433A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments |
| 07/04/2000 | US6084130 For treatment of central nervous system disorders |
| 07/04/2000 | CA1341044C Benzopyrido piperidine, piperidylidene and peperazine compounds, compositions, methods of manufacture and methods of use |
| 06/29/2000 | WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 06/28/2000 | EP1012145A1 Alkoxy-substituted compounds, methods, and compositions for inhibiting parp activity |
| 06/28/2000 | CN1258281A Liquid benz-iso-quinoline derivs. |
| 06/27/2000 | US6080852 4,7-dichlororhodamine dyes |
| 06/27/2000 | US6080752 For treating condition which requires antagonism of a dopamine receptor such as psychtic condition |
| 06/22/2000 | WO2000035457A1 Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males |
| 06/22/2000 | CA2354601A1 Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males |
| 06/21/2000 | EP1010731A2 Process for the preparation of highly chromatic perylene pigments |
| 06/21/2000 | EP1009739A2 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| 06/21/2000 | CN1257484A Synthesis of intermediates useful in preparing tricyclic compounds |
| 06/20/2000 | US6077850 Useful for treating cyclooxygenase-2 mediated disorders, such as inflammation and inflammation-related disorders |
| 06/20/2000 | US6077845 As analgesic for alleviating pain |